Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for pa ...

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...

PHILADELPHIA, PA — Pennsylvania legislative leaders will facilitate a forward-looking discussion on medical cannabis at the ...

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

A new analysis finds that evidence of constipation-fighting benefits is strongest for certain food, drinks, and supplements.

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical ...

Given the unmet need of fatigue in primary biliary cholangitis (PBC), the PBC working group of the European Reference Network for Rare Liver Diseases assessed and summarised the current evidence ...

The one-hour session, "Seeing Beyond Vision Loss: A Focus on Mental Health Resources for Patients with Retinal Disease," will ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that it will participate in an ophthalmology panel at the upcoming 2025 Maxim Growth ...